Business Archives

U.S. strikes $230 million deal for over-the-counter Covid tests

The Biden administration announced a $230 million deal to ramp up production of the country’s first over-the-counter, at-home Covid-19 test. “These are over-the-counter, self-performed test kits that can detect Covid with roughly 95 percent accuracy within 15 minutes,” Andy Slavitt, the White House senior adviser for Covid-19 response, told reporters on Monday.

A fast, at-home coronavirus test will be available to Americans this year

The White House announced Monday it is buying 8.5 million rapid coronavirus tests that can be taken at home without a prescription and that yield immediate results. The $231.8 million contract will allow the Australian company Ellume, which manufacturers the tests, to quickly scale up its production and create a manufacturing facility in the United States.Once running, […]

U.S. Cuts $231 Million Deal To Provide 15-Minute COVID-19 At-Home Tests

The Biden administration has made a $231.8 million deal with an Australian company to boost availability of the first at-home rapid test for the coronavirus which causes COVID-19 that is available without a prescription. The test, made by Ellume, can send results to a smartphone within 15 minutes of receiving a sample.

US Government signs deal to produce Australian COVID-19 Home Test kits

Ellume Founder, CEO and Managing Director Dr Sean Parsons spoke with David Koch on Channel 7’s Sunrise program last week to discuss Ellume’s US$231.8 million contract with the U.S. Government to establish a U.S. manufacturing facility and deliver 8.5 million COVID-19 home tests across the U.S in the coming months.

Ellume Announces $231.8 Million Agreement with the U.S. Government

The contract includes the delivery of 8.5 million Ellume COVID-19 Home Tests to support the U.S. Government’s pandemic response The investment will support the establishment of Ellume’s first U.S. manufacturing facility, increasing Ellume’s global production capacity by 500,000+ tests per day once completed; The investment extends Ellume’s engagement with the U.S. government following the NIH […]

BBC World Service Radio Brisbane Interview with Ellume CEO

17 December 2020, Victoria Craig Ellume Founder, CEO and Managing Director Dr Sean Parsons was recently interviewed by BBC World Service Radio’s Victoria Craig about our innovative Ellume COVID-19 Home Test receiving Emergency Use Authorization from the US FDA and how our products are responding to the COVID-19 pandemic.

FDA authorizes Ellume COVID-19 Home Test as First Over-the-Counter Fully At-Home Diagnostic Test

Proven performance in adults and children, with and without symptoms Highlights FDA grants Emergency Use Authorization for Ellume COVID-19 Home Test for non-prescription home use in symptomatic and asymptomatic individuals The test demonstrated 96% accuracy in a multi-site US clinical study of both adults and children 2 years and above Ellume is ramping up manufacture, […]

Ellume’s COVID-19 Home Test shows 96% accuracy in multi-site US clinical study

Highlights Ellume submits Emergency Use Authorization to the U.S. Food and Drug Administration for the Ellume COVID-19 home test Clinical study demonstrated overall sensitivity of 95% and specificity of 97% Clinically validated for use in symptomatic and asymptomatic users ages 2 years and above Independently run, simulated home-use clinical study of 198 subjects Ellume is […]

ABC Radio “The Money” Interview with Ellume CEO, Dr Sean Parsons

29 October 2020, Richard Aedy Ellume Founder, CEO and Managing Director Dr Sean Parsons was interviewed by ABC Radio’s Richard Aedy on The Money program about how the company is scaling up its Brisbane manufacturing facilities as part of a US push to develop rapid COVID-19 testing technology. This interview originally appeared on ABC Radio […]

Ellume enlists Bosch Australia to automate manufacturing for high-performance COVID-19 Test

Highlights Ellume will collaborate with Bosch to create state-of-the-art automated production lines, to scale up manufacturing volumes of COVID-19 and other diagnostic tests. Bosch capabilities will build resilience and innovation into the local Ellume manufacturing processes. Bosch global automation and manufacturing know-how harnessed to ensure successful industrialisation of Ellume COVID-19 consumable test. New Ellume manufacturing […]

Page 1 of 412 3 4